395 related articles for article (PubMed ID: 26170288)
1. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells.
Wan CK; Andraski AB; Spolski R; Li P; Kazemian M; Oh J; Samsel L; Swanson PA; McGavern DB; Sampaio EP; Freeman AF; Milner JD; Holland SM; Leonard WJ
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9394-9. PubMed ID: 26170288
[TBL] [Abstract][Full Text] [Related]
2. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
3. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.
Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T
J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135
[TBL] [Abstract][Full Text] [Related]
4. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
5. IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3.
Wang H; Meng R; Li Z; Yang B; Liu Y; Huang F; Zhang J; Chen H; Wu C
Immunol Lett; 2011 Apr; 136(1):21-8. PubMed ID: 21115047
[TBL] [Abstract][Full Text] [Related]
6. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
[TBL] [Abstract][Full Text] [Related]
7. IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3.
Kamiya S; Okumura M; Chiba Y; Fukawa T; Nakamura C; Nimura N; Mizuguchi J; Wada S; Yoshimoto T
Immunol Lett; 2011 Jul; 138(1):47-53. PubMed ID: 21453726
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells.
Ray JP; Marshall HD; Laidlaw BJ; Staron MM; Kaech SM; Craft J
Immunity; 2014 Mar; 40(3):367-77. PubMed ID: 24631156
[TBL] [Abstract][Full Text] [Related]
9. IL-6 activates STAT5 in T cells.
Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
[TBL] [Abstract][Full Text] [Related]
10. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
[TBL] [Abstract][Full Text] [Related]
11. Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection.
Carbo A; Olivares-Villagómez D; Hontecillas R; Bassaganya-Riera J; Chaturvedi R; Piazuelo MB; Delgado A; Washington MK; Wilson KT; Algood HM
mBio; 2014 Jul; 5(4):e01243-14. PubMed ID: 25053783
[TBL] [Abstract][Full Text] [Related]
12. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
[TBL] [Abstract][Full Text] [Related]
14. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
15. Human T
Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
[TBL] [Abstract][Full Text] [Related]
16. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
Nieminen JK; Niemi M; Sipponen T; Salo HM; Klemetti P; Färkkilä M; Vakkila J; Vaarala O
PLoS One; 2013; 8(8):e70738. PubMed ID: 23950992
[TBL] [Abstract][Full Text] [Related]
18. STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production.
Owaki T; Asakawa M; Morishima N; Mizoguchi I; Fukai F; Takeda K; Mizuguchi J; Yoshimoto T
J Immunol; 2008 Mar; 180(5):2903-11. PubMed ID: 18292512
[TBL] [Abstract][Full Text] [Related]
19. Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors.
Govender U; Corre B; Bourdache Y; Pellegrini S; Michel F
J Leukoc Biol; 2017 May; 101(5):1181-1190. PubMed ID: 28242623
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
